Many Americans have COVID-19 vaccine preferences

Many americans have COVID-19 vaccine preferences

(HealthDay)—Nearly three-quarters of Americans say they have a preference for a specific COVID-19 vaccine, a new survey finds.

The of 1,000 people found that most (36 percent) preferred Pfizer, followed by Moderna at 19 percent and Johnson & Johnson at 17 percent, CBS News reported.

Reasons cited for wanting the Pfizer vaccine include the vaccine's efficacy (45 percent), positive study data (35 percent), reportedly fewer side effects (32 percent), reading a positive news story (29 percent), and social media posts by family and friends (21 percent), according to the results of the survey by M Booth Health, a health communications consultancy, and Savanta, a and advisory company.

Among those who preferred the Moderna vaccine, common reasons included efficacy (32 percent), fewer side effects (31 percent), positive study data (30 percent), and by family and friends (23 percent), CBS News reported.

Those who wanted the Johnson & Johnson listed reasons such as the fact that it requires only one shot (31 percent), preexisting trust in the brand (26 percent), or "good experiences" with the company's products in the past (19 percent).

More information: CBS News Article

Copyright © 2021 HealthDay. All rights reserved.

Citation: Many Americans have COVID-19 vaccine preferences (2021, April 30) retrieved 19 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak


Feedback to editors